A two-year old in North Dakota was born with a heart twice as large as it should be with two extra holes, a heart defect that was allegedly caused by her mother’ use of a medication now involved in several Zofran lawsuits.

A report on March 17th tells the story of a little girl who is preparing for a surgery in May that will hopefully undo damage that allegedly resulted from the anti-nausea medication, which she was exposed to in the womb after her mother was prescribed it during her first trimester of pregnancy. According to the article, which was published in Valley News Live, the child was initially taken to the doctor for a fever and left with a diagnosis that was obtained through an X-ray. “I thought it was just a fever and then you walk out thinking what’s wrong with my kid you know. This is heartbreaking,” remembers her mother, who believes her daughter’s problems would have been avoided if she didn’t take Zofran, which is not even approved for use in pregnant women.

The medication is in fact only cleared by the U.S. Food and Drug Administration (FDA) to treat chemotherapy, radiation and surgery patients.

Zofran Not Tested in Pregnant Women, Article Points Out

Zofran hasn’t even been tested in this pregnant women because the U.S. Food and Drug Administration (FDA) typically shies away from doing studies on them. A local pharmacist quoted in the story says this is because “You’d put pregnant mothers and their children at risk.”

The drug’s manufacturer, GlaxoSmithKline, admitted to the lack of research involving pregnant women in a Toronto Star investigation from last year. Zofran has not been proven effective in treating pregnant women, the company said in a June 2014 report.

Nevertheless, the medication continues to be prescribed and is now named in several Zofran lawsuits that allege serious birth defects born to babies exposed to it. Plaintiffs in these cases allege cleft lip and palates, heart and kidney defects and certain abnormalities with the brain that could lead to cerebral palsy and other serious developmental conditions. They further allege that GlaxoSmithKline concealed vital safety data pertaining to Zofran birth defects, and promoted its product for uses not approved by the FDA.

Call a Zofran Lawyer

Contact a Zofran lawyer at our Firm today for information on how to pursue legal action against its manufacturer. Call us now at (877) 779-1414.

Published March 19, 2015 by